中枢性睡眠呼吸暂停与心房纤颤、心力衰竭的研究进展

doi:10.3969/j.issn.1003-9198.2021.08.001

摘要/Abstract

中图分类号:

朱祎娜, 张希龙, 陈仁杰, 冯旰珠, 翁晓芹, 王文晶. 中枢性睡眠呼吸暂停与心房纤颤、心力衰竭的研究进展[J]. 实用老年医学, 2021, 35(8): 789-794.

[1] BAILLIEUL S, REVOL B, JULLIAN-DESAYES L, et al. Diagnosis and management of central sleep opnea syndrom[J]. Expert Revpir Med, 2019, 13(6): 545-557.
[2] MARTIN R R, BATES M D. Management of atrial fibrillation and concomitant coronary artery disease[J]. Continuing Cardiol Education, 2017, 3(2) :47-55.
[3] DAI H, ZHANG Q, ABU M A, et al. Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990—2017: results from the Global Burden of Disease Study 2017[J]. Eur Heart J Qual Care Clin Outcomes, 2020. DOI: 10.1093/ehjqcco/qcaa061.
[4] GO A S, HYLEK E M, PHILLIPS K A, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study[J]. JAMA, 2001, 285(18): 2370-2375.
[5] ZAKERI R, BORLAUG B A, MCNULTY S, et al. Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study[J]. Circ Heart Fail, 2013,7(1): 123-30.
[6] CHASE D, KUMAR V, HOODA A. Dual-site right ventricular and left ventricular pacing in a patient with left ventricular systolic dysfunction and atrial fibrillation using a standard CRT-D device[J]. J Saudi Heart Assoc, 2013, 25(3): 213-218.
[7] JONES J D, KHAND A U, DOUGLAS H, et al. The intersection of atrial fibrillation and heart failure in a hospitalized population[J]. Acta Cardiol, 2013, 68(4): 395-402.
[8] HARMON E K, PATRICK S, SAMI I, et al. Atrial fibrillation is associated with central sleep apnea in clinic patients undergoing diagnostic polysomnography[J]. J Arrhythm, 2020, 36(6): 991-996.
[9] SANCHEZ A M, ROBIN G, LOZIER M R,et al. Central sleep apnea and atrial fibrillation: a review on pathophysiological mechanisms and therapeutic implications[J]. Int J Cardiol Heart Vasc, 2020, 30: 100527.
[10] 苏士成,丁宁,张希龙,等. 心衰合并心房颤动患者睡眠呼吸暂停综合征的发生情况及临床特征[J].中华医学杂志,2015,95(40): 3278-3280.
[11] ALSHOAIBI N. Outcome of cardiac monitor during sleep study for screening of subclinical atrial fibrillation[J]. Cureus, 2020, 12(7): e8987.
[12] COSTANZO M R, KHAYAT R, PONIKOWSKI P, et al. Mechanisms and clinical consequences of untreated central sleep apnea in heart failure[J]. J Am Coll Cardiol, 2015, 65(1): 72-84.
[13] HERNANDEZ A V, JEON A, DENEGRI-GALVAN J, et al. Use of adaptive servo ventilation therapy as treatment of sleep-disordered breathing and heart failure: a systematic review and meta-analysis[J]. Sleep Breath, 2020, 24(1): 49-63.
[14] KHAYAT R N, JAVAHERI S, PORTER K, et al. In-hospital management of sleep apnea during heart failure hospitalization: a randomized controlled trial[J]. J Card Fail, 2020, 26(8): 705-712.
[15] FLORAS J S. Sleep apnea and cardiovascular disease: an enigmatic risk factor[J]. Circ Res, 2018, 122(12): 1741-1764.
[16] ANZAI T, GRANDINETTI A, KATZ A R, et al. Association between central sleep apnea and atrial fibrillation/flutter in Japanese-American men: The Kuakini Honolulu heart program (HHP) and Honolulu-Asia aging study (HAAS)[J]. J Electrocardiol, 2020, 61:10-17.
[17] VAHDATPOUR C A, LUEBBERT J J, PALEVSKY H I,et al. Atrial arrhythmias in chronic lung disease-associated pulmonary hypertension [J]. Pulm Circ, 2020, 10(1): 2045894020910685.
[18] SANCHEZ A M, GERMANY R, LOZIER M R, et al. Central sleep apnea and atrial fibrillation: a review on pathophysiological mechanisms and therapeutic implications[J]. Int J Cardio Heart Vasc, 2020, 30:100527.
[19] BABAPOOR-FARROKHRAN S, GILL D, ALZUBI J, et al. Atrial fibrillation: the role of hypoxia-inducible factor-1-regulated cytokines[J]. Mol Cell Biochem, 2021, 476(6): 2283-2293.
[20] ZHANG K, MA Z W, SONG C, et al. Role of ion channels in chronic intermittent hypoxia-induced atrial remodeling in rats [J]. Life Sci, 2020, 254:117797.
[21] TUNG P, LEVITZKY Y S, WANG R, et al. Obstructive and central sleep apnea and the risk of incident atrial fibrillation in a community cohort of men and women[J]. J Am Heart Assoc, 2017, 6(7): e004500.
[22] KWON Y, LOGAN J, PUSALAVIDYASAGAR S, et al. Sleep apnea and heart[J]. Sleep Medicine Research, 2019, 10(2): 67-74.
[23] SADEGHI Y, SEDAGHAT M, MAJEDI M A, et al. Comparative evaluation of therapeutic approaches to central sleep apnea [J]. Adv Biomed Res, 2019, 8: 13.
[24] KUETTING D L R, FEISST A, SPRINKART A M, et al. Effects of a 24-hr-shift-related short-term sleep deprivation on cardiac function: a cardiac magnetic resonance-based study [J]. J Sleep Res, 2019, 28(3): e12665.
[25] SMITH J R, SUTTERFIELD S L, BAUMFALK D R, et al. Left ventricular strain rate is reduced during voluntary apnea in healthy humans [J]. J Appl Physiol, 2017, 123(6): 1730-1737.
[26] ZHAO L, LI S N, ZHANG C, et al. Cardiovascular magnetic resonance-determined left ventricular myocardium impairment is associated with C-reactive protein and ST2 in patients with paroxysmal atrial fibrillation [J]. J Cardiovasc Magn Reson, 2021, 23(1): 30.
[27] LIU L S, CHEN Y B, SHU J, et al. Identification of microRNAs enriched in exosomes in human pericardial fluid of patients with atrial fibrillation based on bioinformatic analysis [J]. J Thorac Dis, 2020, 12(10): 5617-5627.
[28] JAVAHERI S, BARBE F, CAMPOS-RODRIGUEZ F, et al. Sleep apnea: types, mechanisms, and clinical cardiovascular consequences[J]. J Am Coll Cardiol, 2017,69(7): 841-858.
[29] 田彦明.呼吸-交感神经偶联在高血压发病中的作用及其机制研究[D]. 石家庄: 河北医科大学, 2017.
[30] 喻淑慧,李园园,胡克.去肾交感神经术治疗顽固性高血压合并阻塞性睡眠呼吸暂停的研究进展[J]. 中国呼吸与危重监护杂志,2015,14(3): 317-320.
[31] YANG Y X, NING Y, WEN W W, et al. CPAP is associated with decreased risk of AF recurrence in patients with OSA, especially those younger and slimmer: a meta-analysis [J]. J Interv Card Electrophysiol, 2020, 58(3): 369-379.
[32] KONECNY T, BRADY P A, PARK J Y, et al. Usefulness of heart rate control in atrial fibrillation patients with obstructive sleep apnea [J]. Am J Cardiol, 2018, 122(9): 1482-1488.
[33] TAMISIER R, BOCQUILLON V, TREPTOW E, et al. Prevalence and factors contributing to daytime and nocturnal hypoxemia in chronic heart failure patients [J]. Respiration, 2019, 97(3): 213-222.
[34] PRIGENT A, SERANDOUR A L, LURAINE R, et al. Interrelated atrial fibrillation and leaks triggering and maintaining central sleep apnoea and periodic breathing in a CPAP-treated patient [J]. Respirol Case Rep, 2020, 8(8): e00666.
[35] GOUDIS C A, KETIKOGLOU D G.Obstructive sleep and atrial fifibrillation: pathophysiological mechanisms and therapeutic implications [J]. Int J Cardiol, 2017, 230: 293-300.
[36] AURORA R N, CHOWDHURI S, RAMAR K, et al. Tracy, the treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses[J]. Sleep, 2012, 35 (1):17-40.
[37] SCHWARZ E I, SCHERFF F, HAILE S R,et al. Effect of treatment of central sleep apnea/cheyne-stokes respiration on left ventricular ejection fraction in heart failure: a network meta-analysis [J]. J Clin Sleep Med, 2019, 15(12): 1817-1825.
[38] KOLB L, ARZT M, STADLER S, et al. Adaptive servo-ventilation in patients with chronic heart failure and sleep disordered breathing: predictors of usage[J]. Sleep Breath, 2020,25(2): 1135-1145.
[39] PICCINI J P, POKORNEY S D, ANSTROM K J et al. Adaptive servo-ventilation reduces atrial fifibrillation burden in patients with heart failure and sleep apnea[J]. Heart Rhythm, 2019,16(1): 91-97.
[40] LATASTE B, LATASTE A, HOFMANN P, et al. Nocturnal oxygen therapy in patients with chronic heart failure and sleep apnea: a systematic review[J]. Sleep Med, 2016,17 :149-157.
[41] OWIE M R, WOEHRLE H, WEGSCHEIOER K, et al. Adaptive servoventilation for central sleep apnea in systolic heart failure[J]. New Engl J Med,2015,373 (12) :1095-1105.
[42] WONGBOONSIN J,THONGPRAYOON C,BATHINI T,et al. Acetazolamide therapy in patients with heart failure: a meta-analysis[J]. J Clin Med, 2019, 8(3):349.
[43] JULLIAN-DESAYES I,REVOL B,CHAREYRE E,et al. Impact of concomitant medications on obstructive sleep apnoea[J]. Br J Clin Pharmacol, 2017, 83(4): 688-708.
[44] JAGIELSKI D, PONIKOWSKI P, AUGOSTINI R, et al.Transvenous stimulation of the phrenic nerve for the treatment of central sleep apnea: 12 months experience with Remede System[J]. Eur J Heart Fail,2016,18 (11) :1386-1393.
[45] AUGOSTINI R, STELLBRINK C, JAGIELSKI D, et al. Phrenic nerve stimulation is safe and improves sleep and qol in patients with central sleep apnea and atrial fibrillation regardless of heart failure status[J]. J Cardiac Fail, 2019, 25 (8) :S83.

中枢性睡眠呼吸暂停与心房纤颤、心力衰竭的研究进展

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

推荐阅读 10

[1]	周赟, 张影影, 高妍芬. 肺力咳合剂联合噻托溴铵粉雾剂在高龄慢性阻塞性肺疾病病人中的效果观察[J]. 实用老年医学, 2024, 38(10): 1011-1015.
[2]	雷万锋, 马秀红. 老年COPD急性加重期病人血清IL-33/sST2轴表达及其对预后的预测价值[J]. 实用老年医学, 2024, 38(10): 1044-1048.
[3]	徐金燕, 夏聪聪, 杨红美. 老年脑卒中肺部感染风险预测模型的建立及验证[J]. 实用老年医学, 2024, 38(5): 452-437.
[4]	彭泽通, 张尧, 刘斌. 贫血对老年社区获得性肺炎死亡的影响分析[J]. 实用老年医学, 2024, 38(3): 260-264.
[5]	苏雪姣, 刘月, 孙蜀宁. 高龄新型冠状病毒感染老年人外周血液学指标与预后的相关性[J]. 实用老年医学, 2024, 38(3): 291-292.
[6]	张杰斯, 黎艳聪, 卢钻芬, 李明标. 黏液玫瑰单胞菌致COPD急性加重1例及文献分析[J]. 实用老年医学, 2024, 38(3): 322-324.
[7]	王瑞萍, 张妮. COPD病人一氧化碳弥散量与运动耐力、呼吸困难及通气效率的相关性研究[J]. 实用老年医学, 2024, 38(2): 141-144.
[8]	姬泽萱, 冯平, 李峰, 项保利, 冯改霞. 老年男性COPD合并骨质疏松病人睾酮及FGF23、MMP-9水平的变化[J]. 实用老年医学, 2024, 38(2): 176-178.
[9]	周柳青, 周计雪, 柳毅. 抑郁症病人抗抑郁药物治疗中2次发生肺栓塞:2例报道[J]. 实用老年医学, 2024, 38(2): 203-205.
[10]	秦克, 李同林, 华俊萍, 江美芳. 老年COPD稳定期病人经鼻高流量湿化氧疗血清颗粒蛋白前体表达水平及意义[J]. 实用老年医学, 2023, 37(12): 1215-1218.
[11]	李娜, 叶莹, 王鸿林, 周秋红. 老年新型冠状病毒感染病人营养支持的研究进展[J]. 实用老年医学, 2023, 37(11): 1081-1075.
[12]	郭佳丽, 黄淳, 陶子荣, 彭伶丽. 老年新型冠状病毒感染病人俯卧位通气管理的最佳证据总结[J]. 实用老年医学, 2023, 37(11): 1086-1091.
[13]	王雪敬, 邓宝凤, 罗昌春, 赵玉荣, 张爱军, 刘海荣, 赵艳梅. 新型冠状病毒感染期间远程探视系统在老年肿瘤住院病人中的应用[J]. 实用老年医学, 2023, 37(11): 1095-1098.
[14]	陈秋羽, 王展展, 李春华. 肠道菌群相关短链脂肪酸在COPD发病机制中的作用研究进展[J]. 实用老年医学, 2023, 37(11): 1166-1169.
[15]	王世福, 欧宗兴, 符沙沙. 老年COPD相关肺动脉高压病人血管活性肠肽水平及其与高凝、低氧状态和血管内皮功能的相关性[J]. 实用老年医学, 2023, 37(9): 907-910.